Schedule 13G ownership disclosure

OKYO PHARMA LTD

Common · CUSIP: G6724L116

Event date: 2025-07-22

Filing-level shares
1,928,451.00
Percent of class
5.01%
  • LAURA NATALIA MONICA FONDA

    Shares: 1,928,451.00 · Class: 5.01%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-019998
Form type
SCHEDULE 13G
Filer
Fonda Laura Natalia Monica
CIK
CIK 1921627
Filed
Oct 29, 2025
Reporting period
Jul 22, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub